Effectiveness of TNFi versus Non-TNFi Biologics on Disease Activity in Obese Patients with Rheumatoid Arthritis: Data from the ACR's RISE Registry

被引：0
|
作者：
Gianfrancesco, Milena [1 ]
Li, Jing [1 ]
Ja, Clairissa [2 ]
Seet, Andrea [1 ]
Schmajuk, Gabriela [1 ]
Yazdany, Jinoos [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] Univ Calif Davis, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0588
引用
收藏
页码：1193 / 1194
页数：2
相关论文
共 50 条
  • [21] Non-TNFi b/tsDMARDs vs. TNFi in Rheumatoid Arthritis-Interstitial Lung Disease: An Active-Comparator, New-User, Propensity Score Matched Study Using National Veterans Affairs Data
    England, Bryant
    Baker, Joshua
    George, Michael
    Johnson, Tate
    Yang, Yangyuna
    Roul, Punyasha
    Sayles, Harlan
    Yu, Fang
    Rojas, Jorge, Jr.
    Sauer, Brian
    Cannon, Grant
    Curtis, Jeffrey R.
    Mikuls, Ted R.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3119 - 3123
  • [22] A COMPARATIVE EFFECTIVENESS STUDY OF ABATACEPT AND TNFI AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS USING REAL-WORLD DATA
    Alemao, Evo
    Connolly, Sean
    Elbez, Yedid
    Rao, Aarti
    Saini, Yogesh
    Iannaccone, Christine
    Weinblatt, Michael E.
    Shadick, Nancy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1646 - 1647
  • [23] Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Silva-Fernandez, Lucia
    De Cock, Diederik
    Lunt, Mark
    Low, Audrey S.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2018, 57 (09) : 1533 - 1540
  • [24] TNFi Combination Therapy, Switching and Persistence Patterns By Longitudinal Disease Activity Strata in Patients with Rheumatoid Arthritis
    Harrold, Leslie
    Reed, George W.
    Boytsov, Natalie
    Gaich, Carol L.
    Mason, Marc
    Zhang, Xiang
    Larmore, Cynthia J.
    Deveikis, Sabrina
    Araujo, Andre B.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [25] Cardiovascular and Cancer Safety of JAKi Compared to TNFi in Patients with Rheumatoid Arthritis: Results from a National Registry of Advanced Therapies
    Otero-Varela, Lucia
    Sanchez-Piedra, Carlos
    Rubio, Elena Rabadan
    Sarmiento-Monroy, Juan Camilo
    Plasencia-Rodriguez, Chamaida
    Sueiro, Diana
    Martinez, Olga
    Busquets Perez, Noemi
    Freire Gonzalez, Mercedes
    Sanchez-Alonso, Fernando
    Alvaro-Gracia, Jose Maria
    Castrejon, Isabel
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4574 - 4576
  • [26] SERIOUS INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS TREATED WITH TNFI: DATA FROM THE NOR-DMARD STUDY.
    Christensen, I. Egeland
    Lillegraven, S.
    Sexton, J.
    Kvien, T. K.
    Uhlig, T.
    Provan, S. Aarrestad
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1673 - 1674
  • [27] Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry
    John Tesser
    Iris Lin
    Natalie J. Shiff
    Soumya D. Chakravarty
    Gabriela Schmajuk
    Nevin Hammam
    Sheetal Desai
    Clinical Rheumatology, 2022, 41 : 2319 - 2327
  • [28] Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry
    Tesser, John
    Lin, Iris
    Shiff, Natalie J.
    Chakravarty, Soumya D.
    Schmajuk, Gabriela
    Hammam, Nevin
    Desai, Sheetal
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2319 - 2327
  • [29] Comparisons of Non-TNFi Biologic and Targeted Synthetic DMARDs in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Propensity Score-Matched Study Using National Veterans Affairs Data
    Frideres, Halie
    Wichman, Christopher
    Dong, Jianghu
    Roul, Punyasha
    Yang, Yangyuna
    Baker, Joshua
    George, Michael
    Johnson, Tate
    Rojas, Jorge
    Brian, Sauer
    Cannon, Grant
    Matson, Scott
    Curtis, Jeffrey
    Mikuls, Ted
    England, Bryant
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3495 - 3497
  • [30] AFTER DISCONTINUATION OF THE 1ST TUMOR NECROSIS FACTOR INHIBITOR (TNFI), NON-TNFI BIOLOGIC AGENTS HAVE SIMILAR RESPONSES BUT HIGHER SURVIVAL COMPARED TO A 2ND COURSE OF A DIFFERENT TNFI: LONG-TERM PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS IN A TERTIARY HOSPITAL OF GREECE
    Flouri, I. D.
    Repa, A.
    Avgouslidis, N.
    Kougas, N.
    Fanouriakis, A.
    Papalopoulos, I.
    Adamichou, C.
    Kyfonidou, P.
    Kampouraki, E.
    Terizaki, M.
    Boumpas, D. T.
    Bertsias, G.
    Sidiropoulos, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 574 - 574
12345